Hydrogel-Based Drug Delivery System Market Analysis
HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET ANALYSIS
Hydrogel-Based Drug Delivery System Market, By Source (Natural, Synthetic, and Hybrid), By Application (Cardiology, Oncology, Immunology, Pain Management, and Others), By Route of Delivery (Subcutaneous, Ocular, Oral, Topical, and Others), By End User (Hospitals, Specialty clinics, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
In November 2023, Stanford University, a private research institution in California, U.S., announced the development of an innovative hydrogel drug delivery system. This new system allows patients to replace daily or weekly injections of diabetes and weight management medications, such as Ozempic, Mounjaro, Trulicity, and Victoza, with just one injection every four months.